FRONT YARD OF THE MAIN HOUSE WITH SERVANT QUARTERS BY THE SIDE AT THE END OF THE LONG DRIVEWAY. SOME PHOTOS AND VIDEOS ON THIS SITE, I DO NOT OWN. HOWEVER, I HAVE NO INTENTION IN INFRINGING ON YOUR COPYRIGHTS.

Friday, January 13, 2017

Treasured Photos of UPSCA and Fr John Delaney:1952-1957

Newspaper Clippings on the Death of Fr John Delaney, 1956. Today is the 61st Anniversary of his death. For more details on his life and work in UP Diliman, read, http://davidbkatague.blogspot.com/2016/01/memories-of-my-college-years-in-up.html

The following are old photos I just discovered recently dating from 1952 to 1957 mostly of Macrine's and my UPSCA Activities. UPSCA is the University of the Philippines Student Catholic Action for those of you not familiar with the initial.

1953 UPSCA Choir

Barbecue Party after UPSCA Concert, UP Diliman, 1954

Marinduque Association, Silver Jubilee, Manila Hotel, 1957

UPSCA Social Works with Fr John Delaney, 1952

UPSCA Meeting with Fr Delaney and Tito Tino ( Fr. Constantino Nieva)-President of UPSCA, 1952

Wednesday, January 11, 2017

What's Hot ( Not New) in Parkinson Disease Therapy


Just recently, I learned that there is a new controlled released formulation of Carbo-Levodopa manufactured by Impax Pharmaceuticals called Rytary. Since my wife has PD I was very curious if switching from the immediate release formulation she is currently taking to this controlled release medication will benefit her. The following is an article published by the National Parkinson Foundation that I found very informative.

"The What’s Hot in Parkinson’s disease blog written in April 2013 featured a new extended release dopamine drug called IPX066. This new dopamine formulation achieved full FDA approval in January 2015. The drug is now sold under the name Rytary. At National Parkinson Foundation we frequently hear from Parkinson’s disease patients that current Carbidopa/levodopa medication preparations fail to adequately address disease-related symptoms. In this month’s What’s Hot column we will update you on important information on Rytary, and also offer a few tips for switching.

It is important to understand the reasons that an individual Parkinson’s disease patient may consider an extended release dopamine medication. The frequently cited medication related problems include:

1. Medication dosages taking too long to “kick in” and start working

2. Medication wearing off before the next scheduled medication dose

3. Severe on-off medication fluctuation periods (e.g. rapid cycling during the day ranging from feeling completely on medication to completely off medication)

4. Dyskinesia (too much movement, usually resulting from too high of a blood level of dopamine)

5. Too many pills:

6. Too many medication dosage intervals (e.g. taking medications every 1-2 hours throughout the waking day).

Patients may also have other disease related issues that levodopa preparations will not address, including walking, balance, talking, and thinking issues, but these will likely require a totally different approach than simple levodopa replacement or Rytary. Dr. Robert Hauser at the National Parkinson Foundation Center of Excellence at the University of South Florida, along with colleagues from 68 North American and European study sites, recently published a paper on a new extended release formulation of carbidopa/levodopa (IPX066 now called Rytary).

The new formulation of carbidopa/levodopa extended release (IPX066/Rytary), is different than its predecessors. It contains special beads designed to dissolve at different rates within the stomach and the intestines. The medication capsule was designed to provide longer lasting benefit for patients with Parkinson’s disease. The randomized study included 393 Parkinson’s disease patients who reported at least of 2.5 hours of “off time,” defined as periods when they felt the medication was not working. The authors aimed to improve the number of hours of “off time” each day for patients randomized to the new extended release formulation (IPX066/Rytary) as compared to the older and standard regular release carbidopa/levodopa. The results revealed that the group on extended release formulations took less overall medication dosages (3.6 vs. 5 doses per day); however they also took more total pills. The daily “off-time” improved by over an hour each day in the extended release formulation. Both medications in this trial were safe and well tolerated.

If we return to the six areas (listed above in bullet points) where Parkinson’s disease patients have been seeking improved medication formulations, Rytary was observed to improve issues in two categories: wearing off between dosages, and improvement by increasing the time interval between dosages. The results of the current study cannot be widely applied to patients with severe dyskinesia, severe on-off fluctuations, and later stage disease. The new extended release formulation also increased the total blood-stream levodopa exposure by 30-40% as compared to conventional immediate release levodopa. Increasing levodopa in the bloodstream is thought to decrease the threshold for dyskinesia, and this has been observed with other Parkinson’s drugs such as Entacapone and Stalevo. Although dosed less frequently, the extended release formulation can require more total pills per day (see FDA conversion table below). The authors of the Rytary study felt that a newer formulation of the same drug, which they anticipate will be used in future clinical practice, would allow for a decrease in pill number. 

In a recent interview with the lead author, Dr. Hauser, we addressed some of the important tips for switching to Rytary.
Though it is unknown who the “best” patients in clinical practice will be, it is suspected that patients with bothersome motor fluctuations, and patients taking a minimum of four 25/100 Sinemet regular or extended release (or the equivalent Madopar dosing) may be reasonable candidates.

Patients with motor fluctuations on three doses of Sinemet or Madopar could benefit, but a satisfactory benefit could possibly be obtained by adding a dose of Sinemet or Madopar rather than switching to Rytary. There may be select patients who can take a Rytary dose that is approximately three times the usual individual Sinemet or Madopar doses, and be able to maintain three times a day dosing at least for a period of time (i.e. before disease progression).

Dosages of Rytary are not interchangeable with other levodopa (Sinemet or Madopar) products. The capsules can be opened and the contents sprinkled onto foods such as apple sauce, if swallowing problems are present. The most important information for patients and families is to avoid magical thinking when switching to the Rytary formulation of levodopa. Further dose adjustments will be likely after the initial medication switch. It will be important for the patient, family, and doctor to discuss the symptoms and optimize and tweak dosages and intervals on the Rytary formulation.

Patients and families should be excited by the news of this new formulation of carbidopa/levodopa. However, patients and clinicians should be aware that there are limitations in the use of Rytary, and that caution should be exercised, especially because in select cases dyskinesia may manifest after switching. Dosages and dosage intervals of any formulation of carbidopa/levodopa, including Rytary, should be carefully adjusted at each clinic visit to address changes in Parkinson’s symptoms.

Patients may also be slightly disappointed that 3-4 capsules of Rytary may need to be taken at each dosage interval. The success or failure of dopamine replacement therapy will always be more dependent on the expert adjusting the therapy than the formulation itself. The “timing is critical principle” from Parkinson’s Treatment: 10 Secrets to a Happier Life should be considered during dose adjustments for any Parkinson’s disease patient. It is really positive news that drug manufacturers are now listening to Parkinson’s disease patients, and are trying to address the major concerns, though there is a lot of room for improvement and more formulations in the marketplace.

Source: http://www.parkinson.org/find-help/blogs/whats-hot/february-2015

Personal Conclusion: As of today, My wife will not benefit switching from her current immediate release medication since she is taking less than 4 pills a day. Moreover, this new drug is much more expensive than my wife's current immediate released formulation medication.

Tuesday, January 10, 2017

What Do You Know about Colorectal Cancer?


Colorectal Cancer malady is closed to my heart. In the late 1990's I was diagnosed with stage 1 colon cancer. The cancer was removed by surgery and I am fine. On the other hand my son-in-law died four years ago from Colon cancer because it was not diagnosed early. It was already on stage 4 when he learned he had the disease. Because of this I did some web search on the prevalence of the disease in the US. Here's what I found.

Excluding skin cancers, colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. The American Cancer Society’s estimates for the number of colorectal cancer cases in the United States for 2016 are:5,270 new cases of colon cancer and 39,220 new cases of rectal cancer.

Overall, the lifetime risk of developing colorectal cancer is: about 1 in 21 (4.7%) for men and 1 in 23 (4.4%) for women. This risk is slightly lower in women than in men. A number of other factors (described in Colorectal cancer risk factors) can also affect your risk for developing colorectal cancer.

Colorectal cancer is the third leading cause of cancer-related deaths in the United States when men and women are considered separately, and the second leading cause when both sexes are combined. It is expected to cause about 49,190 deaths during 2016.

The death rate (the number of deaths per 100,000 people per year) from colorectal cancer has been dropping in both men and women for several decades. There are a number of likely reasons for this. One is that colorectal polyps are now being found more often by screening and removed before they can develop into cancers or are being found earlier when the disease is easier to treat. In addition, treatment for colorectal cancer has improved over the last few decades. As a result, there are now more than 1 million survivors of colorectal cancer in the United States.

Visit the American Cancer Society’s Cancer Statistics Center for more key statistics.

Source: www.cancer.org/colorectal

Monday, January 9, 2017

My Neighbor Had Retinal Detachment Surgery


Three months ago, I heard that my neighbor across the street had some serious eye problem that required immediate attention. I was not sure what was his exact eye problem, but I did not see him doing yard work or drive to the grocery store for almost two months. I saw his wife doing all the yard work and all the driving. I heard he was not allowed to do anything even doing computer work that he loved. I also heard that his frequent use of his computer was probably the cause of his eye problem*.

Last week, I finally saw him tinkering on his car on his driveway. I went across the street and asked him exactly what happened to his eye.

He told me he had retina detachment but is now fixed. He said he had a gas bubble injected into his eye( pneumatic retinopexy) and he is now OK. I was curious of what he told me and about the gas bubble injection. I did some Web search and here's a summary of what I learned about Retina Detachment and its treatment.

Retina Detachment a very serious eye condition that happens when the retina separates from the tissue around it. Since the retina can't work properly under these conditions, you could permanently lose vision if the detached retina isn't repaired promptly. Retinal detachment is an emergency situation in which a thin layer of tissue (the retina) at the back of the eye pulls away from its normal position. Retinal detachment separates the retinal cells from the layer of blood vessels that provides oxygen and nourishment. The longer retinal detachment goes untreated, the greater your risk of permanent vision loss in the affected eye. Retinal detachments affect between 0.6 and 1.8 people per 10,000 per year. About 0.3% of people are affected at some point in their life. It is most common in people who are in their 60s or 70s. Males are more often affected than females.

Warning signs of retinal detachment include the sudden appearance of floaters and flashes and reduced vision. Contact your an eye specialist (ophthalmologist) right away if you want to save your vision.

There are four methods for the treatment for retinal Detachment as follows:

1. Laser (thermal) or freezing (cryopexy). Both of these approaches can repair a tear in the retina if it is diagnosed early enough. This procedure is often done in the doctor's office.

2. Pneumatic retinopexy. This procedure can be used to treat retinal detachment if the tear is small and easy to close. A small gas bubble is injected into the eye (specifically into the clear, gel-like substance between the lens and the retina), where it then rises and presses against the retina, closing the tear. A laser or cryopexy can then be used to seal the tear.

3. Scleral buckle. This treatment for retinal detachment involves surgically sewing a silicone band (buckle) around the white of the eye (called the sclera) to push the sclera toward the tear until the tear heals. This band is not visible and remains permanently attached. Laser or cryo treatment may then be necessary to seal the tear.

4. Vitrectomy.
This surgery for retinal detachment is used for large tears. During a vitrectomy, the doctor removes the vitreous (the clear, gel-like substance between eye's lens and retina) and replaces it with a saline solution. Depending on the complexity of the retinal detachment, various combinations of vitrectomy, buckle, laser and gas bubble may be used to repair the retina.

Reference and Source: http://www.mayoclinic.org/diseases-conditions/retinal-detachment/home/ovc-20197289

*Can prolonged used of computers cause retina detachment? Read: http://www.wwiipress.net/news-experts/2016-07-30/72636.html

Thursday, January 5, 2017

My Favorite Coffee Table Books and the Juan Luna Paintings


The last couple of months I have posted articles on my ties and caps/hats collection. Today I will discuss some of my favorite Coffee Table Books in my collection. I have more than 70 Coffee books in my collection. The photo above is just part of my collection. Two dozens more of my coffee books are under the coffee table that is not pictured in this blog. Topics of my collection are in art, sculptures and painting, Gardening and Landscaping, Food and Nutrition, Travel, erotic art and photography. My ten favorite coffee books are:

1. Robert Mapplethorpe by Richard Howard and Ingrid Sischy, Bulfinch Press, 1988 ( 210 pages)

2. Erotic Art compiled by Phyllis and Eberhard Kronhausen, Bell Publishing Company, 1968 ( 250 pages)

3. Amorsolo ( Paintings) published by Filipinas Foundation, Inc, First Printing, 1975 ( 315 pages)

4. Japanese Eroticism, Text by Bernard Soulle, Crescent Books, N.Y., 1981 (320 pages)

5. 20th Century Masters of Erotic Art by Bradley Smith, Crown Publisher, 1980 ( 380 pages)

6. Augustin Pajou, Royal Sculpture, by James David Draper, Metropolitan Museum of Art, NY, 1998 ( 430 pages)
Marinduque from the Air

7. Marinduque, Heart of the Philippines by Dindo Asuncion, Published by the Provincial Government, 2004 ( 220 pages)

8. The Great Book of French Impressionism by Diane Kelder, Harrison House, NY, 1979 (450 pages)

9. The Complete Cartoons of the New Yorker, Foreword by David Remnick and Edited by Robert Mankoff, Leventhal Publishers, 2004 (520 pages).

10. American Painting, Introduction by Robert Rosenblum and Text by Donald Goddard, Beaux Arts Edition, NY 1990 ( 530 pages)

I should rotate this photo, but I will not so it is easier to read the titles of the books.

Note: I have two coffee table books authored and published by Macrine's first cousin, Bing Nieva Carrion Buck. I have more than 600 hard books and novels and more than a thousand pocket books. I have donated almost all of my pocket books to Goodwill and Salvation Army. I have more than 50 albums of photographs and 90% of my photos are in the web.

A note about coffee table books: A coffee table book is an oversized, usually hard-covered book whose purpose is for display on a table intended for use in an area in which one entertains guests and from which it can serve to inspire conversation. Subject matter is predominantly non-fiction and pictorial (a photo-book).

Pages consist mainly of photographs and illustrations, accompanied by captions and small blocks of text, as opposed to long prose. Since they are aimed at anyone who might pick up the book for a light read, the analysis inside is often more basic and with less jargon than other books on the subject. Because of this, the term "coffee table book" can be used pejoratively to indicate a superficial approach to the subject.

The late Dr. Teyet Pascual and his Collections of Paintings in his Condo in Makati, Manila

In 2005, I had an opportunity to purchase a coffee Table book of some of Juan Luna paintings collected by my former chemistry classmate, the late Dr. Eleuterio (Teyet) Pascual, Ph.D.( http://www.pressreader.com/philippines/philippine-daily-inquirer/20151101/282127815344995).

At that time he was selling it during our Chemistry Alumni Reunion and 50th Anniversary Party for P5,000. I thought it was expensive so I did not buy the coffee table book( it was about $125 at that time based on the pesos to dollars exchange rate). I am now regretting that I did not purchase the Juan Luna Paintings Coffee Table book. (http://lifestyle.inquirer.net/231631/fabulous-works-by-luna-and-19th-century-masters-repatriated/).

Anyway, here's a short video on the Juan Luna paintings that has never shown to the public.


One of the many well-known paintings of Luna is the La Bulaquena ( the Woman from Bulacan). Below is description of the painting from Wikipedia for your information if you are not Filipino and not familiar with Philippine culture and traditions.


La Bulaqueña, literally "the woman from Bulacan" or "the Bulacan woman", also sometimes referred to as Una Bulaqueña ("a woman from Bulacan"). This is the Spanish title of an 1895 painting by Filipino painter and hero Juan Novicio Luna. Bulacan is a province in the Philippines in Luzon island and its residents are called Bulaqueños, also spelled as Bulakenyos (Bulakenyo for men and Bulakenya for women) in the Filipino language.

This is a "serene portrait", of a Filipino woman wearing a Maria Clara gown, a traditional Filipino dress that is composed of four pieces, namely the camisa, the saya (long skirt), the panuelo (neck cover), and the tapis (knee-length overskirt). The name of the dress is an eponym to Maria Clara, the mestiza heroine of Filipino hero José Rizal's novel Noli Me Tangere. The woman's clothing in the painting is the reason why the masterpiece is alternately referred to as Maria Clara. It is one of the few canvases done by Luna illustrating Filipino culture. The painting is displayed at the National Museum of Fine Arts.